Harmony Biosciences Holdings, Inc.
HRMYUS売上高
$868M
百万USD
営業利益
$208M
百万USD
純利益
$159M
百万USD
ROE
18.2%
最新FY
EPS
$2.71
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $60M | $7M | $0.13 |
| FY2021 | Q2 | $74M | $14M | $0.24 |
| FY2021 | Q3 | $81M | $-10M | $-0.17 |
| FY2021 | FY | $305M | $35M | $0.58 |
| FY2022 | Q1 | $85M | $21M | $0.35 |
| FY2022 | Q2 | $107M | $24M | $0.39 |
| FY2022 | Q3 | $117M | $88M | $1.44 |
| FY2022 | FY | $438M | $181M | $2.97 |
| FY2023 | Q1 | $119M | $29M | $0.48 |
| FY2023 | Q2 | $134M | $34M | $0.56 |
| FY2023 | Q3 | $160M | $38M | $0.63 |
| FY2023 | FY | $582M | $129M | $2.13 |
| FY2024 | Q1 | $155M | $38M | $0.67 |
| FY2024 | Q2 | $173M | $12M | $0.20 |
| FY2024 | Q3 | $186M | $46M | $0.79 |
| FY2024 | FY | $715M | $145M | $2.51 |
| FY2025 | Q1 | $185M | $46M | $0.78 |
| FY2025 | Q2 | $200M | $40M | $0.68 |
| FY2025 | Q3 | $239M | $51M | $0.87 |
| FY2025 | FY | $868M | $159M | $2.71 |
| FY2026 | Q1 | $215M | $32M | $0.55 |
財務データ
| 指標 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| 売上高 | $160M | $305M | $438M | $582M | $715M | $868M |
| 営業利益 | $17M | $88M | $120M | $192M | $191M | $208M |
| 純利益 | $-37M | $35M | $181M | $129M | $145M | $159M |
| 総資産 | $427M | $433M | $674M | $811M | $999M | $1.3B |
| 純資産 | - | - | - | - | - | - |
| 自己資本 | $97M | $187M | $403M | $467M | $659M | $870M |
| 営業CF | $-3M | $99M | $144M | $219M | $220M | $348M |
| EPS | $-2.48 | $0.58 | $2.97 | $2.13 | $2.51 | $2.71 |
| BPS | $1.71 | $3.17 | $6.76 | $8.23 | $11.49 | $15.05 |
| ROE | -38.0% | 18.5% | 45.0% | 27.6% | 22.1% | 18.2% |